These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8708753)

  • 1. In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.
    Debbia EA; Campora U; Massaro S; Boldrini E; Schito GC
    J Chemother; 1996 Apr; 8(2):96-101. PubMed ID: 8708753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
    Lövgren T; Salmela I
    Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):155-8. PubMed ID: 102108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
    Lin PR; Shaio MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.
    Krieger JN; Dickins CS; Rein MF
    Antimicrob Agents Chemother; 1985 Mar; 27(3):332-6. PubMed ID: 3873214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
    Smith RF; Di Domenico A
    Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
    Mabaso N; Abbai N
    Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.